208 related articles for article (PubMed ID: 11366234)
1. Vaccine to prevent AIDS.
Tyring S
Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234
[TBL] [Abstract][Full Text] [Related]
2. Vaccine to prevent AIDS overstated.
Lewis D
Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223
[TBL] [Abstract][Full Text] [Related]
3. Vaccine fundamentals.
Simmons P
Res Initiat Treat Action; 1999 Jan; 5(1):8. PubMed ID: 11366233
[TBL] [Abstract][Full Text] [Related]
4. Progress and obstacles in the development of an AIDS vaccine.
Letvin NL
Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
[TBL] [Abstract][Full Text] [Related]
5. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
7. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
8. [The quest for an HIV vaccine].
Girard MP
Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
[TBL] [Abstract][Full Text] [Related]
9. AIDS vaccine development: the long and winding road.
Garber DA; Feinberg MB
AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 immunogen (remune).
Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
[TBL] [Abstract][Full Text] [Related]
11. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
12. HIV vaccines: new frontiers in vaccine development.
Duerr A; Wasserheit JN; Corey L
Clin Infect Dis; 2006 Aug; 43(4):500-11. PubMed ID: 16838241
[TBL] [Abstract][Full Text] [Related]
13. No vaccine against HIV yet--are we not perfectly equipped?
Singh M
Virol J; 2006 Aug; 3():60. PubMed ID: 16939652
[TBL] [Abstract][Full Text] [Related]
14. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
15. Development of prophylactic AIDS vaccines: the current state of affairs.
Hanke T
Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
[TBL] [Abstract][Full Text] [Related]
16. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
Wright PF; Mestecky J; McElrath MJ; Keefer MC; Gorse GJ; Goepfert PA; Moldoveanu Z; Schwartz D; Spearman PW; El Habib R; Spring MD; Zhu Y; Smith C; Flores J; Weinhold KJ;
J Infect Dis; 2004 Apr; 189(7):1221-31. PubMed ID: 15031791
[TBL] [Abstract][Full Text] [Related]
17. Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.
Desrosiers R
J Int Assoc Physicians AIDS Care; 1998 Mar; 4(3):45-6. PubMed ID: 11365180
[TBL] [Abstract][Full Text] [Related]
18. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
Heeney JL; Hahn BH
AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
[No Abstract] [Full Text] [Related]
19. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
Abbas UL
Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
[TBL] [Abstract][Full Text] [Related]
20. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
